Optimal use of UHR QTOF to support fast-moving ADC pipelines

323 views

|

November 27, 2019

  • Share
  • Bruker’s maXis II equips biopharma scientists with powerful capabilities to determine antibody drug conjugates stability in vivo and characterizing the main biotransformation pathways. Find out more in this webinar.

    ChromatographyDiagnosticsForensic ScienceMass Spectrometry

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.